- Disease
- Program
- Target
- Indications
- Discovery
- PCC
- Preclinical Research
- IND
- Phase I
- Phase II
- Phase III
- NDA
-
Approved
USA
|
CHINA
- Cancers
- HJ-002
-
PROTAC
EGFR
-
NSCLC
-
-
-
-
-
-
- HJ-004
-
PROTAC
EGFR
-
Advanced
Malignancies
-
-
-
-
-
-
- HJ-001
-
Inhibitor
EED
-
Solid
Tumors
-
-
-
-
-
-
- CNS
- HJ-006
-
Undisclosed
-
MDD
-
-
-
- Autoimmune Disease
- HJ-007
-
IL-18R
-
Undisclosed
-
-
